17 Jan Keywords: bicarbonate, dichloroacetate, glioma, hyperpolarized 13C therapies and metabolic modulation, with improved ef- fectiveness have. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Metabolic modulation of glioblastoma with dichloroacetate. Metabolic modulation as a novel Keywords: cancer, metabolic, apoptosis, dichloroacetate, glycolysis .. modulation of glioblastoma with dichloroacetate.

Author: Nall Gosho
Country: Bahrain
Language: English (Spanish)
Genre: Literature
Published (Last): 4 November 2005
Pages: 242
PDF File Size: 16.82 Mb
ePub File Size: 10.8 Mb
ISBN: 402-8-26917-213-9
Downloads: 87420
Price: Free* [*Free Regsitration Required]
Uploader: Nanos

Add to My Bibliography. Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts.

Solid tumors, including the aggressive primary brain cancer glioblastoma dichloroacetare, develop resistance to cell death, in part as a result of a switch from mitochondrial oxidative phosphorylation to cytoplasmic glycolysis.

Writing — original draft: Dual-targeting of aberrant glucose metabolism in glioblastoma. Association of reactive oxygen species levels and radioresistance in cancer stem cells. However, following a separate Phase I dose-escalation study, Siu-Chung Chu et al concluded that DCA will be minimally effective as a single-agent and would be best used in combination with therapies that would benefit from enhanced oxidative metabolism [ 23 ].

Evidence from a new murine tumor model. The Wnt target metabolic modulation of glioblastoma with dichloroacetate Peter Pan defines a novel pindependent nucleolar stress-response pathway. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain.

Metabolic Modulation of Glioblastoma with Dichloroacetate | Science Translational Medicine

Posted on June 3, in History. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo.

Michelakis – University of Alberta G. Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma. The anti-diabetic drug metformin has displayed metabolic modulation of glioblastoma with dichloroacetate activity towards cancer, both cell-autonomous glloblastoma indirect metabolic effects [ 50 — 53 ].

Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a modualtion agent in advanced non-small cell lung cancer Edward B. Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. This is likely an effect of the degree of complex I inhibition as metformin is thought to be only a mild inhibitor of complex I [ metabolic modulation of glioblastoma with dichloroacetate ].

VM-M3 cells are derived from an extremely aggressive spontaneous mouse brain tumor and exhibit a dependency on glycolytic metabolism [ 4142 ]. Jiang W, Finniss S. Metabolic Modulation of Glioblastoma with Dichloroacetate. The culture media was then replaced and treatment applied for 24 hours. DCA depolarized mitochondria, increased mitochondrial reactive oxygen species, and induced apoptosis in GBM cells, as well as in putative GBM stem cells, both in vitro and in vivo.

The activation of pyruvate dehydrogenase promotes flux of glucose carbon through the TCA cycle, subsequently increasing the rate of NADH generation [ 3647 ]. Metformin treatment is often associated with the stimulation of AMPK, which contributes to the anti-diabetic activity of the agent [ 57 ].

metabolic modulation of glioblastoma with dichloroacetate Metabolic modulation of glioblastoma with dichloroacetate download — By jeffrey dach md.

Gammer – University dichlorocaetate Alberta J. This metabolic remodeling is accompanied by mitochondrial hyperpolarization. Rotenone inhibits the transfer of electrons from iron sulfur clusters resident in complex I of the ETC to ubiquinone, leading to inefficient NADH oxidation [ 55 ]. We sought to characterize the necessity of complex I inhibition in the efficacy of the combination.

Following a ten-minute incubation, fixed cells were visualized with a Nikon TEE fluorescence microscope and a 40X objective lens. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.

Metabolic Modulation of Glioblastoma with Dichloroacetate

Similarly, rotenone enhanced oxidative stress resultant from DCA treatment and this too was required for the noted augmentation of cytotoxicity.

Similar Papers Loading similar papers…. Metformin treatment does not diminish VM-M3 viability. To assess this, we utilized the complex I inhibitor metformin. The average relative fluorescence intensity of individual cells within 10 fields of view were determined for each treatment. The small-molecule pyruvate mimetic dichloroacetate DCA is being evaluated as an adjuvant to chemotherapy because of its propensity metabolic modulation of glioblastoma with dichloroacetate enhance oxidative stress [ 11 — 16 ].

Metabolic modulation of glioblastoma with dichloroacetate. – PubMed – NCBI

Metformin, a cationic biguanide, readily accumulates in the mitochondria, where it inhibits complex I of the electron transport chain ETC [ 2627 ]. In fact, it has been recently reported that metformin does enhance oxidative stress in the presence of DCA treatment in breast cancer cells [ 2425 ]. Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather metabolic modulation of glioblastoma with dichloroacetate as a single agent in advanced non-small cell lung cancer Edward B.

Culture media was then replaced and treatment applied. Metformin is under intense investigation as an anti-cancer therapy for both tumor cell-autonomous activity as well as indirect activities in lowering systemic glucose and insulin that have largely been attributed to the reduced incidence of certain cancers in diabetic patients taking metformin [ 29 — 32 ]. Indeed, recently Jiang et al reported that DCA enhanced the efficacy of phenformin in prolonging survival in an orthotopic GSC model [ 67 metabolic modulation of glioblastoma with dichloroacetate.